Early pacemaker implantation for transcatheter aortic valve implantation is safe and effective,Pacing and Clinical Electrophysiology

当前位置： X-MOL 学术 › Pacing Clin. Electrophysiol. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Early pacemaker implantation for transcatheter aortic valve implantation is safe and effective
Pacing and Clinical Electrophysiology ( IF 1.7 ) Pub Date : 2021-11-02 , DOI: 10.1111/pace.14397
Kush P Patel _{1,

2} , Wei Yao Lim ₁ , Asha Pavithran ₁ , Rangeena Assadi ₁ , Daniel Wan ₁ , Simon Kennon ₁ , Mick Ozkor ₁ , Mark Earley ₁ , Simon Sporton ₁ , Mehul Dhinoja ₁ , Carl Hayward ₁ , Amal Muthumala ₁ , Ross Hunter _{1,

3} , Martin Lowe ₁ , Pier Lambiase _{1,

3} , Oliver Segal ₁ , Anthony Mathur _{1,

3} , Richard Schilling _{1,

3} , Andreas Baumbach _{1,

3,

4} , Michael J Mullen ₁ , Anthony WC Chow _{1,

3}

Affiliation

Permanent pacemaker (PPM) implantation is a common complication of transcatheter aortic valve implantation (TAVI). The optimum timing of PPM implantation is still unclear as conduction abnormalities evolve and a balance needs to be struck between conservative delays in the hope of conduction recovery and overutilization of pacing. This study aimed to assess the safety and efficacy of early PPM implantation, without an observation period, among TAVI patients.

中文翻译：

经导管主动脉瓣植入术早期植入起搏器安全有效

永久性起搏器 (PPM) 植入是经导管主动脉瓣植入 (TAVI) 的常见并发症。随着传导异常的发展，PPM 植入的最佳时机仍不清楚，需要在保守延迟之间取得平衡，以期恢复传导和过度使用起搏。本研究旨在评估 TAVI 患者早期 PPM 植入的安全性和有效性，无需观察期。

更新日期：2021-11-02

点击分享查看原文

点击收藏

阅读更多本刊最新论文